38.51 USD
+0.65 (+1.72%)
38.51 USD
0 (0%)
Taking everything into account, COGT scores 2 out of 10 in our fundamental rating. COGT was compared to 525 industry peers in the Biotechnology industry. COGT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. COGT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- COGT had negative earnings in the past year.
- In the past year COGT has reported a negative cash flow from operations.
- COGT had negative earnings in each of the past 5 years.
- COGT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -50.42%, COGT perfoms like the industry average, outperforming 49.90% of the companies in the same industry.
- COGT has a Return On Equity of -71.01%. This is comparable to the rest of the industry: COGT outperforms 55.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -50.42% | ||
| ROE | -71.01% | ||
| ROIC | N/A |
ROA(3y)-52.46%
ROA(5y)-51.99%
ROE(3y)-64.47%
ROE(5y)-60.7%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- COGT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, COGT has more shares outstanding
- The number of shares outstanding for COGT has been increased compared to 5 years ago.
- COGT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- COGT has an Altman-Z score of 27.79. This indicates that COGT is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 27.79, COGT belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
- COGT has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
- COGT has a Debt to Equity ratio of 0.15. This is in the lower half of the industry: COGT underperforms 63.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 27.79 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 6.38 indicates that COGT has no problem at all paying its short term obligations.
- With a decent Current ratio value of 6.38, COGT is doing good in the industry, outperforming 65.14% of the companies in the same industry.
- A Quick Ratio of 6.38 indicates that COGT has no problem at all paying its short term obligations.
- With a decent Quick ratio value of 6.38, COGT is doing good in the industry, outperforming 66.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.38 | ||
| Quick Ratio | 6.38 |
3. Growth
3.1 Past
- COGT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.66%, which is quite impressive.
EPS 1Y (TTM)32.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.88%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 26.39% on average over the next years. This is a very strong growth
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-16.58%
EPS Next 2Y5.49%
EPS Next 3Y21.85%
EPS Next 5Y26.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for COGT. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for COGT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as COGT's earnings are expected to grow with 21.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.49%
EPS Next 3Y21.85%
5. Dividend
5.1 Amount
- No dividends for COGT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
COGENT BIOSCIENCES INC / COGT FAQ
What is the fundamental rating for COGT stock?
ChartMill assigns a fundamental rating of 2 / 10 to COGT.
Can you provide the valuation status for COGENT BIOSCIENCES INC?
ChartMill assigns a valuation rating of 1 / 10 to COGENT BIOSCIENCES INC (COGT). This can be considered as Overvalued.
What is the profitability of COGT stock?
COGENT BIOSCIENCES INC (COGT) has a profitability rating of 1 / 10.